Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Innovive reaches SPA agreement with FDA for pivotal phase II trial of tamibarotene

Aug. 8, 2007

Hana Biosciences begins phase II trial of Marqibo for ALL

Aug. 8, 2007

Phase II trial of Antisoma's AS-1411 in AML begins

Aug. 8, 2007

Array to initiate phase I trial of ErbB-2 inhibitor ARRY-380 for cancer

Aug. 8, 2007

Phase III studies show Vidaza significantly increases survival in MDS

Aug. 8, 2007

Kosan enrolls patients in phase II/III trial of Hsp90 inhibitor tanespimycin

Aug. 8, 2007

Deforolimus new nonproprietary name for Ariad's AP-23573

Aug. 8, 2007

Enzon enrolls patients in PEG-SN38 phase I study for solid tumors or lymphoma

Aug. 7, 2007

OncoGenex begins enrollment for OGX-427 phase I trial for cancer

Aug. 7, 2007

First-in-man study of a compound targeting CENP-E

Aug. 7, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Taiwan biotech looks outward in next phase of growth
BioWorld
Taiwan’s biotechnology sector was built around domestic health needs, including vaccines and drug manufacturing, but it is increasingly looking outward – to...